Belka C - Search Results

1

FET-PET for malignant glioma treatment planning.

Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, la Fougère C, Belka C. Niyazi M, et al. Among authors: belka c. Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30. Radiother Oncol. 2011. PMID: 21458093

2

CT-guided percutaneous drainage of intra-abdominal abscesses: APACHE III score stratification of 1-year results. Acute Physiology, Age, Chronic Health Evaluation.

Betsch A, Wiskirchen J, Trübenbach J, Manncke KH, Belka C, Claussen CD, Duda SH. Betsch A, et al. Among authors: belka c. Eur Radiol. 2002 Dec;12(12):2883-9. doi: 10.1007/s00330-002-1398-y. Epub 2002 May 8. Eur Radiol. 2002. PMID: 12439565

3

70 Gy or more: which dose for which prostate cancer?

Ganswindt U, Paulsen F, Anastasiadis AG, Stenzl A, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. J Cancer Res Clin Oncol. 2005 Jul;131(7):407-19. doi: 10.1007/s00432-005-0681-0. Epub 2005 May 11. J Cancer Res Clin Oncol. 2005. PMID: 15887028 Review.

4

Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.

Ganswindt U, Paulsen F, Corvin S, Eichhorn K, Glocker S, Hundt I, Birkner M, Alber M, Anastasiadis A, Stenzl A, Bares R, Budach W, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. BMC Cancer. 2005 Jul 28;5:91. doi: 10.1186/1471-2407-5-91. BMC Cancer. 2005. PMID: 16048656 Free PMC article.

5

Treatment-outcome for synchronous head-and-neck and oesophageal squamous cell carcinoma.

Welz S, Schmid A, Hehr T, Schulze K, Feldmann HJ, Budach W, Bamberg M, Belka C. Welz S, et al. Among authors: belka c. Radiother Oncol. 2005 Dec;77(3):267-70. doi: 10.1016/j.radonc.2005.07.004. Epub 2005 Sep 9. Radiother Oncol. 2005. PMID: 16154220

6

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study.

Ganswindt U, Budach W, Jendrossek V, Becker G, Bamberg M, Belka C. Ganswindt U, et al. Among authors: belka c. Radiat Oncol. 2006 Apr 10;1:9. doi: 10.1186/1748-717X-1-9. Radiat Oncol. 2006. PMID: 16722607 Free PMC article. Clinical Trial.

7

First experiences of radiation treatment planning with PET/CT.

Paulsen F, Scheiderbauer J, Eschmann SM, Brechtel K, Klein M, Pfannenberg C, Mondry A, Hehr T, Belka C, Bamberg M. Paulsen F, et al. Among authors: belka c. Strahlenther Onkol. 2006 Jul;182(7):369-75. doi: 10.1007/s00066-006-1451-x. Strahlenther Onkol. 2006. PMID: 16826354

8

Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of protein kinase B/Akt-mediated survival-signaling.

Handrick R, Rübel A, Faltin H, Eibl H, Belka C, Jendrossek V. Handrick R, et al. Among authors: belka c. Radiother Oncol. 2006 Aug;80(2):199-206. doi: 10.1016/j.radonc.2006.07.021. Epub 2006 Aug 17. Radiother Oncol. 2006. PMID: 16916558

9

[Recurrence of prostate cancer--value of salvage radiotherapy].

Belka C, Ganswindt U. Belka C, et al. Urologe A. 2006 Oct;45(10):1266-70. doi: 10.1007/s00120-006-1210-8. Urologe A. 2006. PMID: 17006699 Review. German.

10

Isobologram analysis of triple therapies.

Niyazi M, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2006 Oct 17;1:39. doi: 10.1186/1748-717X-1-39. Radiat Oncol. 2006. PMID: 17044920 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

632 results

Search Page